Published in J Immunol on December 01, 1974
Epitope-specific tolerance induction with an engineered immunoglobulin. Proc Natl Acad Sci U S A (1996) 1.24
Antigen mediation of a late-acting suppressor T-cell activity. J Exp Med (1977) 0.97
Deregulation of idiotype expression. Induction of tolerance in an anti-idiotypic response. J Exp Med (1982) 0.77
Inhibitory effect of carrier and hapten preimmunization on delayed hypersensitivity to the carrier. Immunology (1976) 0.75
Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation (1995) 2.36
Determination of total and merecaptothanol-resistant antibody in the same serum sample. Clin Exp Immunol (1970) 2.36
Hyperadrenocorticism in association with an adrenocortical adenoma in a pet ferret. Can Vet J (1989) 2.03
The identification of sera distinguishing marrow-derived and thymus-derived lymphocytes in the rat thoracic duct. Immunology (1974) 1.49
Immunologic skin disorders in the dog and cat. Vet Clin North Am (1978) 1.44
Nosocomial H1N1 infection during 2010-2011 pandemic: a retrospective cohort study from a tertiary referral hospital. J Hosp Infect (2012) 1.41
A survey of canine and feline skin disorders seen in a university practice: Small Animal Clinic, University of Montréal, Saint-Hyacinthe, Québec (1987-1988). Can Vet J (1990) 1.41
Idiopathic linear pustular acantholytic dermatosis in a young Brittany Spaniel dog. Vet Dermatol (2001) 1.39
Eosinophilic intracytoplasmic globules in pulmonary adenocarcinomas: a histochemical, immunohistochemical, and ultrastructural study of six cases. Hum Pathol (1989) 1.39
The distribution of organs for transplantation. What is fair and practical? N C Med J (1991) 1.37
Activation-induced apoptosis in lymphocytes. Curr Opin Immunol (1994) 1.34
Role of IgD in the immune response and tolerance. I. Anti-delta pretreatment facilitates tolerance induction in adult B cells in vitro. J Exp Med (1977) 1.33
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J Exp Med (1986) 1.33
Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. Transplantation (1987) 1.31
Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J Comp Neurol (1993) 1.29
The role of recirculating lymphocytes in the immunological competence of rat bone marrow cells. Cell Immunol (1972) 1.28
Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation (2001) 1.24
Epitope-specific tolerance induction with an engineered immunoglobulin. Proc Natl Acad Sci U S A (1996) 1.24
Genetics, cellular expression and function of IgD and IgM receptors. Immunol Rev (1977) 1.24
Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol (1993) 1.24
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest (2000) 1.22
Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol (1996) 1.18
Sporotrichosis in three dogs. Cornell Vet (1974) 1.17
Collaboration between thymus-derived and marrow-derived thoracic duct lymphocytes in the hemolysin response of the rat. Cell Immunol (1972) 1.17
Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J Immunol (2000) 1.17
Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther (2000) 1.17
Multiple pathways of B lymphocyte tolerance. Immunol Rev (1979) 1.17
Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc Natl Acad Sci U S A (1999) 1.15
Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype. Proc Natl Acad Sci U S A (1988) 1.14
Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants. Cell Immunol (1985) 1.13
Regulation of the G1 phase of the mammalian cell cycle. Cell Res (2000) 1.13
Measuring contributions to the research mission of medical schools. Acad Med (2000) 1.12
Nonsteroidal management of canine pruritus with amitriptyline. Cornell Vet (1992) 1.11
Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. N Engl J Med (1986) 1.11
Clinical efficacy of milbemycin oxime in the treatment of generalized demodicosis in adult dogs. J Am Vet Med Assoc (1993) 1.10
Benefits of HLA-A and HLA-B matching on graft and patient outcome after cadaveric-donor renal transplantation. N Engl J Med (1984) 1.10
Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J Exp Med (1994) 1.10
Factors affecting the choice of hospital-based ambulatory care by the urban poor. Am J Public Health (1977) 1.09
Efficacy of chlorpheniramine maleate for management of pruritus in cats. J Am Vet Med Assoc (1990) 1.09
Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc Natl Acad Sci U S A (1993) 1.09
Mechanism of immunologic tolerance. I. Induction of tolerance to bovine gamma-globulin by injection of antigen into intact organs in vitro. J Immunol (1969) 1.09
Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol Immunol (1999) 1.08
Neoplasms of the apocrine sweat glands in 44 dogs and 10 cats. Vet Rec (1990) 1.07
Role of self-carriers in the immune response and tolerance. I. B-cell unresponsiveness and cytotoxic T-cell immunity induced by haptenated syngeneic lymphoid cells. J Exp Med (1976) 1.07
Humoral rejection of rat hepatic transplants by passive transfer of serum. Transplant Proc (1987) 1.07
Differential expression of a surface antigen recognized by a monoclonal antibody, J11d, on unprimed and primed B cells. J Immunol (1986) 1.04
Role of self carriers in the immune response and tolerance. III. B cell tolerance induced by hapten-modified-self involves both active T cell-mediated suppression and direct blockade. Cell Immunol (1978) 1.04
Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol Med (1997) 1.04
Mechanobullous disease in two Belgian foals. Equine Vet J (1989) 1.03
Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Gene Ther (2004) 1.02
Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur J Immunol (1986) 1.00
Zoonotic dermatoses of dogs and cats. Vet Clin North Am Small Anim Pract (1987) 1.00
Comprehensive multidisciplinary treatment of chronic pain: a follow-up study of treated and non-treated groups. Pain (1991) 1.00
A clinical trial on the efficacy of clemastine in the management of allergic pruritus in dogs. Can Vet J (1993) 0.99
Signalling in B cells. Immunol Today (1991) 0.98
Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. J Immunol (1994) 0.98
Canine demodicosis. Vet Clin North Am Small Anim Pract (1979) 0.98
C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol (1999) 0.98
BCL2 mutations in diffuse large B-cell lymphoma. Leukemia (2011) 0.98
Pathology of human mesothelioma. Etiologic and diagnostic considerations. Pathol Annu (1987) 0.97
Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. J Immunol (1997) 0.97
The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea. Transplantation (1986) 0.97
Cellular events in tolerance. IV. The effect of a graft-versus-host reaction and endotoxin on hapten- and carrier-specific tolerance. Eur J Immunol (1974) 0.96
HLA matching in renal transplantation. N Engl J Med (1994) 0.96
Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer. Eur J Immunol (2000) 0.95
Evaluation of an allergy screening test for use in atopic dogs. J Am Vet Med Assoc (1992) 0.95
Cellular events in tolerance. VI. Neonatal vs adult B cell tolerance: differences in antigen-binding cell patterns and lipopolysaccharide stimulation. J Immunol (1977) 0.95
The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol (1984) 0.95
Feline papillomas and papillomaviruses. Vet Pathol (2000) 0.95
The anti-delta suppressed mouse. Eur J Immunol (1978) 0.94
Activation-induced cell death in B lymphocytes. Cell Res (2000) 0.94
Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation (1999) 0.93
Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation (1982) 0.93
Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Differ (1992) 0.93
B-cell receptor and Fas-mediated signals for life and death. Immunol Rev (2000) 0.93
Immunohistochemical manifestations of unilateral kidney ischemia. Clin Transplant (1996) 0.92
Therapeutic hypothermia: heat transfer from warmed tracheal tubes to oesophageal temperature probes poses risk of life-threatening overcooling. Br J Anaesth (2012) 0.92
Clinical efficacy of increased dosages of milbemycin oxime for treatment of generalized demodicosis in adult dogs. J Am Vet Med Assoc (1995) 0.92
Hapten-specific murine colony-forming B cells: in vitro response of colonies to fluoresceinated thymus independent antigens. J Immunol (1981) 0.91
Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year posttransplantation--SEOPF 1977-1982. South-Eastern Organ Procurement Foundation. Transplantation (1987) 0.91
Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses. Transplantation (1990) 0.91
Cholelithiasis in a dog. J Am Vet Med Assoc (1973) 0.91
Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol (1993) 0.91
Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. Lab Invest (1978) 0.91
Antifluorescein affinity columns. Isolation and immunocompetence of lymphocytes that bind fluoresceinated antigens in vivo or in vitro. J Exp Med (1976) 0.90
The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation (1984) 0.90
Tetracycline and niacinamide for the treatment of sterile pyogranuloma/granuloma syndrome in a dog. J Am Anim Hosp Assoc (1998) 0.90
Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas. Mol Biol Cell (1996) 0.90
Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation (1986) 0.89
Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection. Am J Pathol (1993) 0.89
Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. Arch Pathol Lab Med (1987) 0.89
Retrospective study of clinical observations on insect hypersensitivity and response to immunotherapy in allergic dogs. Can Vet J (2001) 0.89
The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. Transplantation (1995) 0.88
Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. Am J Clin Pathol (1985) 0.88
Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int (1992) 0.88
Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas. J Immunol (2001) 0.87
Persistence of antigen-binding cells with surface tolerogen: isologous versus heterologous immunoglobulin carriers. J Immunol (1977) 0.87
The comparative pathology of non-viral bullous skin diseases in domestic animals. Vet Pathol (1980) 0.87
Tolerance in vitro: suppression of immune responsiveness to bovine gamma-globulin after injection of antigen into intact lymphoid organs. J Immunol (1968) 0.87